Published Date : Oct 27, 2015
xCouncil of Scientific and Industrial Research (CSIR) lab in Lucknow, India launched its Ayurvedic drug that has been validated to for Type 2 Diabetes. The drug is called BGR-34 and has been co-developed by Central Institute for Medicinal and Aromatic Plant (CIMAP) and National Botanical Research Institute (NBRI). Both these units have been funded by the government. This drug will be manufactured by Aimil Pharmaceuticals in New Delhi.
In an interesting announcement a CSIR official stated that the drug has not been tested on humans. He defended this stand by saying that the pill has no negative side effect, which is why no clinical trial was required. This announcement has made several people skeptical about the herbal remedy.
Dr. AKS Rawat, senior principal scientist at NBRI explained that the drug is made of four plants extracts that Ayurveda mentions will treat the condition and not any adverse effect. However, when this drug was tested on animals, researchers found it to be successful in at least 67% of the cases. This test result has made scientists at CSIR confident that the Ayuvedic anti-diabetes medicine will work without any side effects.
NBRI scientists have also said that the While explaining the working of drug, NBRI scientists said that the drug will boosts the immune system, reduce possibilities of diabetic complications, act as an antioxidant, and make the overall quality of a diabetic patient better.
The negative aspect of this drug is its price. Currently, the BGR-34 is pegged at INR 5 for each tablet, which makes it way costlier than allopathic medicines. The pricing seems shocking since Ayurvedic medicines made in India receive government funding